Patents by Inventor Matthew Stanton

Matthew Stanton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10394804
    Abstract: A method and system increases Internet traffic to a question and answer customer support system, according to one embodiment. The method and system receive a question, and determine a search engine popularity or searchability of the question, according to one embodiment. If the search engine popularity or searchability of the question is less than a threshold, the question is provided to customer support personnel for reformation, according to one embodiment. The question and answer customer support personnel provide question reformation suggests to the customer support personnel, according to one embodiment.
    Type: Grant
    Filed: October 8, 2015
    Date of Patent: August 27, 2019
    Assignee: Intuit Inc.
    Inventors: Igor A. Podgorny, Matthew Cannon, Warren Bartolome, Nolan Richard Patterson, Bradly Stanton Feeley
  • Publication number: 20190255194
    Abstract: The present disclosure provides alternative nucleosides, nucleotides, and nucleic acids, and methods of using them.
    Type: Application
    Filed: March 1, 2019
    Publication date: August 22, 2019
    Inventors: Atanu ROY, Christopher R. CONLEE, Antonin DE FOUGEROLLES, Andrew W. FRALEY, Gabor BUTORA, Matthew STANTON
  • Patent number: 10385088
    Abstract: The present disclosure provides alternative sugar moieties and polynucleotides comprising such sugar moieties, and methods of use thereof.
    Type: Grant
    Filed: October 2, 2014
    Date of Patent: August 20, 2019
    Assignee: ModernaTX, Inc.
    Inventors: Andrew W. Fraley, Atanu Roy, Matthew Stanton
  • Publication number: 20190225644
    Abstract: The present disclosure relates to cap analogs, which can result in high levels of capping efficiency and transcription and improved translation efficiencies. The present disclosure also relates to methods useful for preparing cap analogs and using mRNA species containing such analogs, as well as kits containing the novel cap analogs.
    Type: Application
    Filed: October 17, 2016
    Publication date: July 25, 2019
    Inventors: Gabor BUTORA, Matthew STANTON, Thomas STEELE
  • Publication number: 20190218546
    Abstract: The present disclosure relates to cap analogs, which can result in high levels of capping efficiency and transcription and improved translation efficiencies. The present disclosure also relates to methods useful for preparing cap analogs and using mRNA species containing such analogs, as well as kits containing the novel cap analogs.
    Type: Application
    Filed: October 17, 2016
    Publication date: July 18, 2019
    Inventors: Gabor BUTORA, Matthew STANTON, Thomas STEELE
  • Publication number: 20190218826
    Abstract: An interchangeable electro-mechanical lock core for use with a lock device having a locked state and an unlocked state is disclosed. The interchangeable electromechanical lock core may include a moveable plug having a first position relative to a lock core body which corresponds to the lock device being in the locked state and a second position relative to a lock core body which corresponds to the lock device being in the unlocked state.
    Type: Application
    Filed: October 18, 2017
    Publication date: July 18, 2019
    Inventors: Brendon Allen, Street Anthony Barnett, III, Matthew J. Velderman, Andrew E. Seman, Jr., Ryan H. Quin, Gary Hill, Paul Becke, Christopher W. Lemieux, Anthony Romano, Matthew Stanton
  • Publication number: 20190211368
    Abstract: The present disclosure relates to cap analogs, which can result in high levels of capping efficiency and transcription and improved translation efficiencies. The present disclosure also relates to methods useful for preparing cap analogs and using mRNA species containing such analogs, as well as kits containing the novel cap analogs.
    Type: Application
    Filed: October 17, 2016
    Publication date: July 11, 2019
    Inventors: Gabor BUTORA, Matthew STANTON, Edward John MIRACCO
  • Patent number: 10286086
    Abstract: The present disclosure provides alternative nucleosides, nucleotides, and nucleic acids, and methods of using them.
    Type: Grant
    Filed: June 19, 2015
    Date of Patent: May 14, 2019
    Assignee: ModernaTX, Inc.
    Inventors: Atanu Roy, Christopher R. Conlee, Antonin De Fougerolles, Andrew W. Fraley, Gabor Butora, Matthew Stanton
  • Publication number: 20190092828
    Abstract: The present disclosure provides alternative nucleosides, nucleotides, and nucleic acids, and methods of using them. In some aspects, the disclosure provides mRNA wherein the uracil content has been modified and which may be particularly effective for use in therapeutic compositions, because they may benefit from both high expression levels and limited induction of the innate immune response. In some aspects, the disclosure provides methods for the production of pharmaceutical compositions including mRNA without reverse phase chromatography.
    Type: Application
    Filed: July 30, 2018
    Publication date: March 28, 2019
    Inventors: Stephen G. HOGE, William Joseph ISSA, Edward John MIRACCO, Jennifer NELSON, John REYNDERS, Matthew STANTON
  • Publication number: 20190075724
    Abstract: A lawn mower comprising a frame supported on rotatable wheels for movement over a ground surface; an operator support coupled to the frame and configured to support the entire weight of an operator of the lawn mower during use thereof; a blade assembly comprising one or more blades that are configured to cut grass on the ground surface; a steering system configured to manipulate the steering direction of the wheels; a motor assembly configured to: drive the wheels so as to move the frame along the ground surface; and a first rechargeable battery module removably coupled to the frame and configured to power the motor assembly.
    Type: Application
    Filed: September 12, 2018
    Publication date: March 14, 2019
    Inventors: Paul BECKE, Matthew STANTON, Andrew SEMAN, Matthew VELDERMAN, Daniel WHITE
  • Publication number: 20190075726
    Abstract: The present invention is directed to a small push-type lawn mower that can be converted into a riding mower. The mower includes a platform at the rear of the mower deck, and its handle assembly that can be pivoted forward making room for a user to step onto the platform. The handle assembly includes controls that drive electric motors that power the rear wheels allowing the user to ride the mower. The handle assembly can be pivoted rearwardly so that the user can access and grab the handle assembly and push the mower as is well known.
    Type: Application
    Filed: September 10, 2018
    Publication date: March 14, 2019
    Inventors: Daniel J. WHITE, Matthew J. VELDERMAN, Matthew STANTON
  • Publication number: 20190078087
    Abstract: The disclosure provides polynucleotides encoding a polypeptide including a morpholino linker. In some embodiments, the polynucleotides of the invention have increased stability compared to wild-type polynucleotides.
    Type: Application
    Filed: September 19, 2016
    Publication date: March 14, 2019
    Inventors: Gabor BUTORA, Andrew W. FRALEY, Edward John MIRACCO, Jennifer NELSON, Amy RHODEN-SMITH, Matthew STANTON
  • Patent number: 10147220
    Abstract: A computer-implemented method includes accessing a plurality of sets of outputs for an interactive animation, with each set of outputs being associated with a different sequence of a plurality of sequences of discrete control inputs, and with each set of outputs comprising an output that provides a stored portion of the animation; and transmitting, to a client device, information indicative of at least one of the plurality of sets of outputs for the animation and the output that provides the stored portion of the animation, which when rendered by the client device causes the animation to be presented to a user.
    Type: Grant
    Filed: March 13, 2015
    Date of Patent: December 4, 2018
    Assignee: Carnegie Mellon University
    Inventors: Matthew Stanton, Adrien Treuille, Kayvon Fatahalian, James O'Brien, Ben Humberston, Brandon Kase
  • Publication number: 20180312535
    Abstract: The present disclosure relates to cap analogs, which can result in high levels of capping efficiency and transcription and improved translation efficiencies. The present disclosure also relates to methods useful for preparing cap analogs and using mRNA species containing such analogs, as well as kits containing the novel cap analogs.
    Type: Application
    Filed: June 14, 2018
    Publication date: November 1, 2018
    Inventors: Gabor BUTORA, Matthew STANTON, Thomas STEELE
  • Publication number: 20180305393
    Abstract: The present disclosure relates to cap analogs, which can result in high levels of capping efficiency and transcription and improved translation efficiencies. The present disclosure also relates to methods useful for preparing cap analogs and using mRNA species containing such analogs, as well as kits containing the novel cap analogs.
    Type: Application
    Filed: June 14, 2018
    Publication date: October 25, 2018
    Inventors: Gabor BUTORA, Matthew STANTON, Thomas STEELE
  • Publication number: 20180291055
    Abstract: The present disclosure relates to cap analogs, which can result in high levels of capping efficiency and transcription and improved translation efficiencies. The present disclosure also relates to methods useful for preparing cap analogs and using mRNA species containing such analogs, as well as kits containing the novel cap analogs.
    Type: Application
    Filed: June 14, 2018
    Publication date: October 11, 2018
    Inventors: Gabor BUTORA, Matthew STANTON, Thomas STEELE
  • Publication number: 20180256750
    Abstract: The invention features polynucleotides encoding a polypeptide including a 3?-stabilizing region and having increased stability compared to wild-type polynucleotides.
    Type: Application
    Filed: September 19, 2016
    Publication date: September 13, 2018
    Applicant: MODERNA THERAPEUTICS, INC.
    Inventors: Gabor BUTORA, Andrew W. FRALEY, Edward John MIRACCO, Jennifer NELSON, Amy RHODEN-SMITH, Matthew STANTON
  • Patent number: 10072057
    Abstract: The present disclosure provides alternative nucleosides, nucleotides, and nucleic acids, and methods of using them. In some aspects, the disclosure provides mRNA wherein the uracil content has been modified and which may be particularly effective for use in therapeutic compositions, because they may benefit from both high expression levels and limited induction of the innate immune response. In some aspects, the disclosure provides methods for the production of pharmaceutical compositions including mRNA without reverse phase chromatography.
    Type: Grant
    Filed: July 21, 2017
    Date of Patent: September 11, 2018
    Assignee: ModernaTX, Inc.
    Inventors: Stephen G. Hoge, William Joseph Issa, Edward John Miracco, Jennifer Nelson, John Reynders, Matthew Stanton
  • Publication number: 20180009866
    Abstract: The present disclosure provides alternative nucleosides, nucleotides, and nucleic acids, and methods of using them. In some aspects, the disclosure provides mRNA wherein the uracil content has been modified and which may be particularly effective for use in therapeutic compositions, because they may benefit from both high expression levels and limited induction of the innate immune response. In some aspects, the disclosure provides methods for the production of pharmaceutical compositions including mRNA without reverse phase chromatography.
    Type: Application
    Filed: July 21, 2017
    Publication date: January 11, 2018
    Inventors: Stephen G. Hoge, William Joseph Issa, Edward John Miracco, Jennifer Nelson, John Reynders, Matthew Stanton
  • Patent number: 9751925
    Abstract: The present disclosure provides alternative nucleosides, nucleotides, and nucleic acids, and methods of using them. In some aspects, the disclosure provides mRNA wherein the uracil content has been modified and which may be particularly effective for use in therapeutic compositions, because they may benefit from both high expression levels and limited induction of the innate immune response. In some aspects, the disclosure provides methods for the production of pharmaceutical compositions including mRNA without reverse phase chromatography.
    Type: Grant
    Filed: December 4, 2015
    Date of Patent: September 5, 2017
    Assignee: ModernaTX, Inc.
    Inventors: Stephen G. Hoge, William Joseph Issa, Edward John Miracco, Jennifer Nelson, John Reynders, Matthew Stanton